1B-LSD Legal status
(6aR ,9R )-N ,N -diethyl-7-methyl-4-butanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg ]quinoline-9-carboxamide
CAS Number PubChem CID ChemSpider UNII Formula C 24 H 31 N 3 O 2 Molar mass 393.531 g·mol−1 3D model (JSmol )
CN1[C@](C2=C[C@@H](C(N(CC)CC)=O)C1)([H])CC3=CN(C(CCC)=O)C4=C3C2=CC=C4
InChI=1S/C24H31N3O2/c1-5-9-22(28)27-15-16-13-21-19(18-10-8-11-20(27)23(16)18)12-17(14-25(21)4)24(29)26(6-2)7-3/h8,10-12,15,17,21H,5-7,9,13-14H2,1-4H3/t17-,21-/m1/s1
Key:SVRFNPSJPIDUBC-DYESRHJHSA-N
1B-LSD (N1-butyryl-lysergic acid diethylamide ) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug .[2] In tests on mice it was found to be an active psychedelic, though with only around 1/7th the potency of LSD itself.[3] [4] [5]
Legal status [ ]
1B-LSD is illegal in Singapore.[6] Sweden's public health agency suggested classifying 1B-LSD as a hazardous substance, on June 24, 2019.[7]
See also [ ]
Lysergic acid diethylamide (LSD)
1cP-LSD
1P-LSD
1V-LSD
ALD-52
AL-LAD
ETH-LAD
1P-ETH-LAD
PRO-LAD
LSM-775
LSZ
O-Acetylpsilocin (4-AcO-DMT)
References [ ]
^ "Arrêté du 20 mai 2021 modifiant l'arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants" . www.legifrance.gouv.fr (in French). 20 May 2021.
^ Tsochatzis E, Lopes JA, Reniero F, Holland M, Åberg J, Guillou C (February 2020). "Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics" . Molecules . 25 (3): 712. doi :10.3390/molecules25030712 . PMC 7037844 . PMID 32045999 .
^ Wagmann L, Richter LH, Kehl T, Wack F, Bergstrand MP, Brandt SD, et al. (July 2019). "In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures" (PDF) . Analytical and Bioanalytical Chemistry . 411 (19): 4751–4763. doi :10.1007/s00216-018-1558-9 . PMID 30617391 . S2CID 58615418 .
^ Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Dowling G, et al. (August 2019). "Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD)" . Drug Testing and Analysis . 11 (8): 1122–1133. doi :10.1002/dta.2613 . PMC 6899222 . PMID 31083768 .
^ Halberstadt AL, Chatha M, Klein AK, McCorvy JD, Meyer MR, Wagmann L, et al. (August 2020). "Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD)" (PDF) . Neuropharmacology . 172 : 107856. doi :10.1016/j.neuropharm.2019.107856 . PMID 31756337 . S2CID 208155327 .
^ "Misuse of Drugs Act - Singapore Statutes Online" . sso.agc.gov.sg .
^ "Åtta ämnen föreslås klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 24 June 2019.
Hallucinogens
Psychedelics (5-HT2A agonists)
Benzofurans
2C-B-FLY
2CBFly-NBOMe
5-MeO-BFE
5-MeO-DiBF
Bromo-DragonFLY
F-2
F-22
TFMFly
Lyserg‐ amides Phenethyl‐ amines
Piperazines Tryptamines
alpha -alkyltryptaminesx -DALT
(Daltacetin) 4-AcO-DALT
5-MeO-DALT
DALT
x -DET
(Ethacetin) 4-AcO-DET
(Ethocin) 4-HO-DET
5-MeO-DET
(T-9) DET
(Ethocybin) 4-PO-DET
x -DiPT
(Ipracetin) 4-AcO-DiPT
(Iprocin) 4-HO-DiPT
5-MeO-DiPT
DiPT
x -DMT
4,5-DHP-DMT
2,N,N-TMT
4-AcO-DMT
4-HO-5-MeO-DMT
4-Propionyloxy-DMT
5-AcO-DMT
5-Bromo-DMT
5-MeO-DMT
5-N ,N -TMT
7,N,N-TMT
α,N,N-TMT
(Bufotenin) 5-HO-DMT
DMT
Norbaeocystin
(Psilocin) 4-HO-DMT
(Psilocybin) 4-PO-DMT
x -DPT Ibogaine-related
18-MAC
18-MC
Coronaridine
Ibogaine
Ibogamine
ME-18-MC
Noribogaine
Tabernanthine
Voacangine
x -MET
(Metocin) 4-HO-MET
(Metocetin) 4-AcO-MET
5-MeO-MET
MET
x -MiPT
(Mipracetin) 4-AcO-MiPT
(Miprocin) 4-HO-MiPT
5-Me-MiPT
(Moxy) 5-MeO-MiPT
MiPT
Others
Others
AL-38022A
ALPHA
Dimemebfe
Efavirenz
Glaucine
Lorcaserin
M-ALPHA
RH-34 Also empathogens in general (e. g.: 5-APB , 5-MAPB , 6-APB and other substituted benzofurans ).
Dissociatives (NMDAR antagonists )
Arylcyclo‐ hexylamines
Ketamine-related PCP-related Others
Diarylethylamines Morphinans
Dextrallorphan
Dextromethorphan
Dextrorphan
Racemethorphan
Racemorphan
Others
Deliriants (mAChR antagonists ) Others
Cannabinoids (CB1 agonists)
Natural
Salvinorin A
THC (Dronabinol)
THCV
Synthetic
D2 agonists
Apomorphine
Aporphine
Bromocriptine
Cabergoline
Lisuride
LSD
Memantine
Nuciferine
Pergolide
Phenethylamine
Piribedil
Pramipexole
Ropinirole
Rotigotine
Salvinorin A Also indirect D2 agonists, such as dopamine reuptake inhibitors (cocaine , methylphenidate ), releasing agents (amphetamine , methamphetamine ), and precursors (levodopa ).
GABAA enhancers
CI-966
Eszopiclone
Ibotenic acid
Muscimol (Amanita muscaria )
Zaleplon
Zolpidem
Zopiclone
Inhalants (Mixed MOA )
Aliphatic hydrocarbons
Butane
Gasoline
Kerosene
Propane
Aromatic hydrocarbons
Ethers
Haloalkanes
Chlorofluorocarbons
Chloroform
κOR agonists Oneirogens
Calea zacatechichi
Silene capensis
Galantamine
Others
Glaucine
Isoaminile
Noscapine
Pukateine
Ergolines
Lysergic acid derivatives
2-Bromo-LSD (BOL-148)
Amesergide
Bromocriptine
Cabergoline
Dihydroergocornine
Dihydroergocristine
Dihydroergocryptine
(Dihydroergonovine, Dihydroergobasine)
Dihydroergotamine
Epicriptine
Ergine (LSA; LA-111; Lysergamide)
Ergocornine
Ergocristine
Ergocryptine
Ergoloid (Dihydroergotoxine)
Ergometrine (Ergonovine, Ergobasine)
Ergometrinine
Ergostine
Ergotamine
Ergotoxine
Ergovaline
Lisuride
LY-215,840
LSH
Lysergic acid
Lysergic acid methyl ester
Lysergol
Mesulergine
Metergoline
MIPLA
Methysergide
Sergolexole
Psychedelic lysergamides Clavines
9-Deacetoxyfumigaclavine C
Agroclavine
Chanoclavine
Chanoclavine II
Costaclavin
Cycloclavine
Elymoclavine
Epoxyagroclavine
Festuclavine
Fumigaclavine A
Fumigaclavine B
Fumigaclavine C
Paliclavine
Penniclavine
Setoclavine
Other ergolines Natural sources
Achnatherum robustum (Sleepy Grass)
Claviceps spp. (Ergot)
Morning glory: Argyreia nervosa (Hawaiian Baby Woodrose), Ipomoea spp. (Morning Glory, Tlitliltzin, Badoh Negro), Rivea corymbosa (Coaxihuitl, Ololiúqui)